diagnostic test

UNIV TS - DSV - Lab. Biologia Applicata

Traiettoria di sviluppo tecnologico SmartHealth: 
Biomedicale, Diagnostica in Vivo e VitroTerapia Innovativa

The research activity of the PI group is focused on the development of novel technologies for selecting and validate recombinant antibodies as well as antigens.
Selection of recombinant antibodies for diagnostic and therapeutic interest.
Our group has developed a proprietary Phage display antibody library (Eu patent EP1131421). This library has been licensed for 10 year to CarRA and later to Hermes biosciences.

Traiettoria di sviluppo tecnologico SmartHealth: 
Biomedicale, Diagnostica in Vivo e Vitro
  • ministero dell'istruzione dell'universita e della ricerca
  • regione fvg
  • Area Science Park
  • ProESOF 2020